Astal Laboratories share news and announcements
BSE: 512600Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 23 Oct 2026. Previous close ₹67.85.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹279 Cr2,455th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 14 Aug 2026
- 28.7
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 30 May 2026
- 0.9
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 14 Aug 2026
- 5.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 14 Aug 2026
- 4.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 30 May 2026
- 0.04
- Volume, BSEVolume. Shares traded on the last trading day.
- 13,208
Astal Laboratories share news and announcements
547 announcements, routine notices left out, newest first. Page 3 of 11.
Jan 2025
21 Jan · Board meeting
Meeting on 27 Jan 2025: quarterly results
Dec 2024
23 Dec · Announcement under Regulation 30 (LODR)-Change in Registered Office Address
23 Dec · Meeting
23 Dec · Meeting
Nov 2024
27 Nov · Announcement under Regulation 30 (LODR)-Allotment
22 Nov · Board meeting
Meeting on 27 Nov 202420 Nov · Meeting
14 Nov · Intimation Under Regulation 30 (LODR) Regulations, 2015
6 Nov · Board meeting
Meeting on 12 Nov 2024: quarterly results
Oct 2024
7 Oct · Analysts
Sep 2024
30 Sep · Intimation For Updation Of KYC/Nomination/Bank Detail
Aug 2024
Jul 2024
22 Jul · Board meeting
Meeting on 27 Jul 2024: quarterly results
Jun 2024
28 Jun · Board meeting
Meeting on 6 Jul 2024: annual general meeting and issue of warrants
May 2024
24 May · Intimation Of Keep And Maintain Books Of Accounts At A Place Other Than Registered Office.
24 May · Announcement under Regulation 30 (LODR)-Change in Corporate Office Address
18 May · Board meeting
Meeting on 24 May 2024: audited results and quarterly results
Apr 2024
23 Apr · Announcement under Regulation 30 (LODR)-Change of Company Name